DAIICHISANKYO PHARMA DEVELOPMENT (DS5565-A-E312)

By June 19, 2019 Closed

AN OPEN-LABEL EXTENSION STUDY OF DS-5565 FOR 52 WEEKS IN PAIN ASSOCIATED WITH FIBROMYALGIA

Join the discussion 3 Comments

Leave a Reply